INNATE PHARMA : Expansion of mCRC cohort in Phase I trial evaluating monalizumab with Imfinzi
Mar 23, 2018 06:01 am UTC| Business
Partner MedImmune expands colorectal cancer patient cohort in ongoing PHASE I TRIAL EVALUATING MONALIZUMAB IN COMBINATION WITH IMFINZI® (DURVALUMAB) Additional expansion cohorts to explore the safety and efficacy...
Mar 23, 2018 06:01 am UTC| Business
BASELWORLD: WISeKey Introduced WIS.WATCH new generation of connected watches powered by VaultIC Semiconductor and embedded WISeCoin cryptocurrency wallet WIS.Watch can be reserved directly from www.wis.watch ...
Changing Times: 24-Year-Old UGA Graduate, Colton Moore, Challenges Georgia Republican Leadership
Mar 23, 2018 05:12 am UTC| Business
TRENTON, Ga. and ATLANTA, March 23, 2018 -- Colton Moore (https://ColtonMoore.com), the 24-year-old Republican candidate for Georgia State House District 1, is shaking things up for the Republican Party as one of the...
Amlan to Report on In-Feed Antibiotic Alternatives at Asia Pacific Poultry Conference
Mar 23, 2018 01:52 am UTC| Business
BANGKOK, Thailand, March 22, 2018 -- Amlan International, a leader in the supply of innovative solutions to improve intestinal health and productivity for livestock, announces that Dr. Hyun Soon Lillehoj, a senior...
Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan
Mar 23, 2018 01:30 am UTC| Business
CRANBURY, N.J., March 22, 2018 -- Amicus Therapeutics (Nasdaq:FOLD) announced today that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the oral small molecule pharmacological chaperone Galafold®...
Westport Fuel Systems Reports Fourth Quarter and Fiscal 2017 Financial Results
Mar 23, 2018 01:05 am UTC| Business
VANCOUVER, British Columbia, March 22, 2018 -- Westport Fuel Systems Inc. (“Westport Fuel Systems”) (TSX:WPRT) (Nasdaq:WPRT) reported financial results for the fourth quarter and year ended December 31, 2017 and...
Updated TACTI-mel Data Presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit
Mar 22, 2018 23:45 pm UTC| Business
SYDNEY, Australia, March 22, 2018 -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or the “Company”) is pleased to announce the presentation of updated data from its TACTI-mel Phase I clinical trial in Australia...